Chagas Disease

Fabiana Simão Machado, Herbert B. Tanowitz

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi. It is endemic in many areas of Latin America, where it remains an important cause of morbidity and mortality. It is an important cause of heart disease and gastrointestinal (GI) dysfunction such as megacolon and megaesophagus. There has been increased immigration from endemic areas to North America and Europe, where Chagas disease is recognized with increased frequency as an imported infection. Chagas disease is also an opportunistic infection in immunocompromised individuals, including those with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). The diagnosis of acute infection is based on finding trypomastigotes in the blood, and chronic Chagas disease is suggested by serologic testing. The antiparasitic drugs benznidazole and nifurtimox are used to treat acute infection, but antiparasitic treatment in the chronic phase is not uniformly recommended. The management of chronic chagasic cardiomyopathy is similar to that of cardiomyopathies from other causes. The management of the GI complications generally involves both medical and surgical interventions.

Original languageEnglish (US)
Title of host publicationNetter's Infectious Disease
PublisherElsevier Inc.
Pages532-526
Number of pages7
ISBN (Print)9781437701265, 9781437701265
DOIs
StatePublished - Sep 9 2011

Fingerprint

Chagas Disease
Antiparasitic Agents
Cardiomyopathies
Nifurtimox
Infection
Protozoan Infections
Megacolon
Esophageal Achalasia
Latin America
Trypanosoma cruzi
Opportunistic Infections
Emigration and Immigration
Virus Diseases
North America
Heart Diseases
Parasites
Acquired Immunodeficiency Syndrome
Chronic Disease
HIV
Morbidity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Machado, F. S., & Tanowitz, H. B. (2011). Chagas Disease. In Netter's Infectious Disease (pp. 532-526). Elsevier Inc.. https://doi.org/10.1016/B978-1-4377-0126-5.00086-0

Chagas Disease. / Machado, Fabiana Simão; Tanowitz, Herbert B.

Netter's Infectious Disease. Elsevier Inc., 2011. p. 532-526.

Research output: Chapter in Book/Report/Conference proceedingChapter

Machado, FS & Tanowitz, HB 2011, Chagas Disease. in Netter's Infectious Disease. Elsevier Inc., pp. 532-526. https://doi.org/10.1016/B978-1-4377-0126-5.00086-0
Machado FS, Tanowitz HB. Chagas Disease. In Netter's Infectious Disease. Elsevier Inc. 2011. p. 532-526 https://doi.org/10.1016/B978-1-4377-0126-5.00086-0
Machado, Fabiana Simão ; Tanowitz, Herbert B. / Chagas Disease. Netter's Infectious Disease. Elsevier Inc., 2011. pp. 532-526
@inbook{1491ae0197c94f3b829da8b935275f08,
title = "Chagas Disease",
abstract = "Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi. It is endemic in many areas of Latin America, where it remains an important cause of morbidity and mortality. It is an important cause of heart disease and gastrointestinal (GI) dysfunction such as megacolon and megaesophagus. There has been increased immigration from endemic areas to North America and Europe, where Chagas disease is recognized with increased frequency as an imported infection. Chagas disease is also an opportunistic infection in immunocompromised individuals, including those with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). The diagnosis of acute infection is based on finding trypomastigotes in the blood, and chronic Chagas disease is suggested by serologic testing. The antiparasitic drugs benznidazole and nifurtimox are used to treat acute infection, but antiparasitic treatment in the chronic phase is not uniformly recommended. The management of chronic chagasic cardiomyopathy is similar to that of cardiomyopathies from other causes. The management of the GI complications generally involves both medical and surgical interventions.",
author = "Machado, {Fabiana Sim{\~a}o} and Tanowitz, {Herbert B.}",
year = "2011",
month = "9",
day = "9",
doi = "10.1016/B978-1-4377-0126-5.00086-0",
language = "English (US)",
isbn = "9781437701265",
pages = "532--526",
booktitle = "Netter's Infectious Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Chagas Disease

AU - Machado, Fabiana Simão

AU - Tanowitz, Herbert B.

PY - 2011/9/9

Y1 - 2011/9/9

N2 - Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi. It is endemic in many areas of Latin America, where it remains an important cause of morbidity and mortality. It is an important cause of heart disease and gastrointestinal (GI) dysfunction such as megacolon and megaesophagus. There has been increased immigration from endemic areas to North America and Europe, where Chagas disease is recognized with increased frequency as an imported infection. Chagas disease is also an opportunistic infection in immunocompromised individuals, including those with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). The diagnosis of acute infection is based on finding trypomastigotes in the blood, and chronic Chagas disease is suggested by serologic testing. The antiparasitic drugs benznidazole and nifurtimox are used to treat acute infection, but antiparasitic treatment in the chronic phase is not uniformly recommended. The management of chronic chagasic cardiomyopathy is similar to that of cardiomyopathies from other causes. The management of the GI complications generally involves both medical and surgical interventions.

AB - Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi. It is endemic in many areas of Latin America, where it remains an important cause of morbidity and mortality. It is an important cause of heart disease and gastrointestinal (GI) dysfunction such as megacolon and megaesophagus. There has been increased immigration from endemic areas to North America and Europe, where Chagas disease is recognized with increased frequency as an imported infection. Chagas disease is also an opportunistic infection in immunocompromised individuals, including those with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). The diagnosis of acute infection is based on finding trypomastigotes in the blood, and chronic Chagas disease is suggested by serologic testing. The antiparasitic drugs benznidazole and nifurtimox are used to treat acute infection, but antiparasitic treatment in the chronic phase is not uniformly recommended. The management of chronic chagasic cardiomyopathy is similar to that of cardiomyopathies from other causes. The management of the GI complications generally involves both medical and surgical interventions.

UR - http://www.scopus.com/inward/record.url?scp=84943272820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943272820&partnerID=8YFLogxK

U2 - 10.1016/B978-1-4377-0126-5.00086-0

DO - 10.1016/B978-1-4377-0126-5.00086-0

M3 - Chapter

SN - 9781437701265

SN - 9781437701265

SP - 532

EP - 526

BT - Netter's Infectious Disease

PB - Elsevier Inc.

ER -